[1]张小红.以自我管理为导向的5A护理模式对卵巢癌患者自我效能与负性情绪的影响[J].医学信息,2020,33(03):186-187.[doi:10.3969/j.issn.1006-1959.2020.03.063]
　ZHANG Xiao-hong.Effect of 5A Nursing Model Oriented on Self-management on Self-efficacy and Negative Emotions of Patients with Ovarian Cancer[J].Medical Information,2020,33(03):186-187.[doi:10.3969/j.issn.1006-1959.2020.03.063]
点击复制

以自我管理为导向的5A护理模式对卵巢癌患者自我效能与负性情绪的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年03期
页码:
186-187
栏目:
护理研究
出版日期:
2020-02-01

文章信息/Info

Title:
Effect of 5A Nursing Model Oriented on Self-management on Self-efficacy and Negative Emotions of Patients with Ovarian Cancer
文章编号:
1006-1959（2020）03-0186-02
作者:
张小红
（重庆市九龙坡区中西医结合医院，重庆 401326）
Author(s):
ZHANG Xiao-hong
(Integrated Traditional Chinese and Western Medicine Hospital of Jiulongpo District，Chongqing 401326，China)
关键词:
卵巢癌; 自我管理为导向; 5A护理; 自我效能; 负性情绪
Keywords:
Ovarian cancer; Self-management oriented; 5A nursing; Self-efficacy; Negative emotions
分类号:
R473.73
DOI:
10.3969/j.issn.1006-1959.2020.03.063
文献标志码:
A
摘要:
目的 探讨对卵巢癌患者实施以自我管理为导向的5A护理模式对其自我效能及负性情绪的影响。方法 选择2016年1月~2018年12月我院肿瘤科收治的80例卵巢癌患者作为研究对象，按照随机数字表法分为常规组和干预组，每组40例。常规组行常规护理，干预组在常规护理基础上应用以自我管理为导向的5A护理模式护理，比较两组护理前后负性情绪。使用焦虑自评量表（SAS）评分、抑郁自评量表（SDS）评分、自我效能感量表（GSES）评分及自测健康评定量表（SRHMS）评分。结果 干预组护理后SAS评分、SDS评分分别为（40.16±4.66）分、（41.84±4.26）分，低于常规组的（46.21±5.24）分、（47.34±4.33）分，GSES评分、SRHMS评分分别为（24.55±5.13）分、（70.45±5.36）分，高于常规组的（16.23±4.39）分、（60.23±5.24）分，差异有统计学意义（P＜0.05）。结论 以自我管理为导向的5A护理模式有助于改善卵巢癌患者负性情绪、自我效能及健康情况，值得临床借鉴。
Abstract:
Objective To investigate the effect of self-management oriented 5A nursing mode on ovarian cancer patients’ self-efficacy and negative emotions.Methods 80 patients with ovarian cancer who were treated in the oncology department of our hospital from January 2016 to December 2018 were selected as the research subjects. They were divided into the routine group and the intervention group according to the random number table method， with 40 cases in each group. The routine group received routine nursing care， and the intervention group applied self-management oriented 5A nursing mode nursing on the basis of routine care. The negative emotions before and after the treatment were compared using the anxiety self-assessment scale （SAS） score and the depression self-assessment scale（SDS） score， Self-Efficacy Scale （GSES） score， and Self-Test Health Rating Scale （SRHMS） score.Results The SAS score and SDS score of the intervention group after nursing were （40.16±4.66） points and（41.84±4.26） points， which were lower than the conventional group’s（46.21±5.24） points and（47.34±4.33） points. The GSES score and SRHMS score were respectively was（24.55±5.13） points，（70.45±5.36） points， higher than the conventional group’s （16.23±4.39） points and （60.23±5.24） points，the difference was statistically significant（P<0.05）.Conclusion The self-management oriented 5A nursing model is helpful to improve the negative emotion， self-efficacy and health status of ovarian cancer patients， and it is worthy of clinical reference.

参考文献/References:

[1]段美玲,姚乐英.以自我管理为导向的5A护理对结直肠造口患者自我效能的影响[J].世界华人消化杂志,2016,23(14):2270-2273. [2]郭丽娜.协同护理模式联合心理干预对卵巢囊肿术后患者自我效能及负性情绪的影响[J].中国民康医学,2017,29(19):110-111. [3]王丽明.以自我管理为导向的5A护理模式在卵巢癌患者中的应用效果[J].全科护理,2016,14(12):1194-1196. [4]吴静,高雯,吕宏英,等.自我效能感对化疗期卵巢癌患者生活质量与负性自动思维的影响[J].护理与康复,2017,16(11):1156-1157,1160. [5]何英,朱蓉,卢蛟蕾.基于自我管理导向的5A护理模式在子宫颈癌患者中的应用[J].中国肿瘤临床与康复,2017,23(3):356-358.

相似文献/References:

[1]杨廷双.卵巢癌患者经CT检查和MRI检查的临床效果对比[J].医学信息,2018,31(07):153.[doi:10.3969/j.issn.1006-1959.2018.07.053]
　YANG Ting-shuang.Comparison of Clinical Effects between CT and MRI in Patients with Ovarian Cancer[J].Medical Information,2018,31(03):153.[doi:10.3969/j.issn.1006-1959.2018.07.053]
[2]揭嘉慧,张 颖.卵巢癌与非编码RNA研究进展[J].医学信息,2019,32(05):39.[doi:10.3969/j.issn.1006-1959.2019.05.014]
　JIE Jia-hui,ZHANG Ying.Progress in Research on Ovarian Cancer and Non-coding RNA[J].Medical Information,2019,32(03):39.[doi:10.3969/j.issn.1006-1959.2019.05.014]
[3]林斯婕,吴 璇,覃 桓,等.卵巢癌合并2型糖尿病发生的危险因素分析[J].医学信息,2019,32(05):124.[doi:10.3969/j.issn.1006-1959.2019.05.039]
　LIN Si-jie,WU Xuan,QIN Huan,et al.Analysis of Risk Factors for Ovarian Cancer Complicated with Type 2 Diabetes[J].Medical Information,2019,32(03):124.[doi:10.3969/j.issn.1006-1959.2019.05.039]
[4]李思文,张 燕.不同紫杉醇剂型联合卡铂治疗卵巢癌的疗效研究[J].医学信息,2019,32(07):150.[doi:10.3969/j.issn.1006-1959.2019.07.046]
　LI Si-wen,ZHANG Yan.Therapeutic Effect of Different Paclitaxel Dosage Forms Combined With Carboplatin On Ovarian Cancer[J].Medical Information,2019,32(03):150.[doi:10.3969/j.issn.1006-1959.2019.07.046]
[5]许书凡,庞 华.18F-FDGPET/CT在卵巢癌中的应用研究[J].医学信息,2019,32(08):75.[doi:10.3969/j.issn.1006-1959.2019.08.022]
　XU Shu-fan,PANG Hua.Research on the Application of 18F-FDGPET/CT in Ovarian Cancer[J].Medical Information,2019,32(03):75.[doi:10.3969/j.issn.1006-1959.2019.08.022]
[6]张秀芳,陈 萍.安罗替尼联合顺铂治疗晚期卵巢癌恶性腹腔积液的疗效观察[J].医学信息,2019,32(18):132.[doi:10.3969/j.issn.1006-1959.2019.18.044]
　ZHANG Xiu-fang,CHEN Ping.Efficacy of Erlotinib Combined with Cisplatin in the Treatment of Advanced Ovarian Cancer with Malignant Ascites[J].Medical Information,2019,32(03):132.[doi:10.3969/j.issn.1006-1959.2019.18.044]
[7]黄馨禾,董丹丹,刘 倩.PARP抑制剂在卵巢癌治疗中的研究现状[J].医学信息,2019,32(21):26.[doi:10.3969/j.issn.1006-1959.2019.21.010]
　HUANG Xin-he,DONG Dan-dan,LIU Qian.Research Status of PARP Inhibitors in the Treatment of Ovarian Cancer[J].Medical Information,2019,32(03):26.[doi:10.3969/j.issn.1006-1959.2019.21.010]
[8]王 秦,张家佳,刘成桂,等.高表达IL-12卵巢癌细胞的建立[J].医学信息,2019,32(21):78.[doi:10.3969/j.issn.1006-1959.2019.21.024]
　WANG Qin,ZHANG Jia-jia,LIU Cheng-gui,et al.Establishment of High Expression of IL-12 Ovarian Cancer Cells[J].Medical Information,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.21.024]
[9]钟达媚,张 颖.PCG与卵巢癌关系的研究[J].医学信息,2020,33(01):28.[doi:10.3969/j.issn.1006-1959.2020.01.011]
　ZHONG Da-mei,ZHANG Ying.Study on the Relationship Between PCG and Ovarian Cancer[J].Medical Information,2020,33(03):28.[doi:10.3969/j.issn.1006-1959.2020.01.011]
[10]魏绮琪,张 颖.miR-200c与卵巢癌关系的研究[J].医学信息,2020,33(03):53.[doi:10.3969/j.issn.1006-1959.2020.03.016]
　WEI Qi-qi,ZHANG Ying.Study on the Relationship Between miR-200c and Ovarian Cancer[J].Medical Information,2020,33(03):53.[doi:10.3969/j.issn.1006-1959.2020.03.016]

更新日期/Last Update: 2020-02-01